Effects of premedication withintravenous drugs on caudal block

Effects of premedication with intravenous ketamine and midazolam on success and complication rates of caudal anesthesia in neonates undergoing lower abdominal surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201305164041N8

Enrollment

Registered

2013-05-22

Start date

2013-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower abdominal surgeries. Bilateral inguinal hernia, without obstruction or gangrene

Interventions

Intervention 1: 1-(control group) caudal block with bupivacaine. Intervention 2: intervention group:caudal block with bupivacaine plus intravenous midazolam 0.1 mg/kg & intravenous ketamine 0.3mg/kg.

Treatment - Drugs

1-(control group) caudal block with bupivacaine

intervention group:caudal block with bupivacaine plus intravenous midazolam 0.1 mg/kg & intravenous ketamine 0.3mg/kg

intervention group:caudal block with bupivacaine plus intravenous midazolam 0.1mg/kg

Eligibility

Sex/Gender

All

Age

No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: neonate infants with ASA (American Society of Anesthesiologists) classes 1&2 scheduled to undergo lower abdominal surgeries in a 12 month period. Exclusion critria: existens of pain and lower limb paralysis 15 minutes after the block will be defined as failure of the block and they will be excluded.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Two, 4, 6 and 8 hours postoperative. Method of measurement: Neonatal infant pain scale(NIPS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mahin Seyedhejazi

Tabriz University Of Medical Sciences

seidhejazie@yahoo.com+98 41 1477 3957

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026